+44 1223 790975Journal of Clinical and Experimental Ophthalmology : Citations & Metrics Report
Articles published in Journal of Clinical and Experimental Ophthalmology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Experimental Ophthalmology has got h-index 76, which means every article in Journal of Clinical and Experimental Ophthalmology has got 76 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Experimental Ophthalmology.
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
Year wise published articles |
73 | 66 | 52 | 67 | 74 |
Year wise citations received |
1859 | 1795 | 1358 | 1320 | 1360 |
| Journal total citations count | 19817 |
| Journal impact factor | 4.57 |
| Journal 5 years impact factor | 28.26 |
| Journal cite score | 25.08 |
| Journal h-index | 76 |
| Journal h-index since 2018 | 46 |
Important citations (627)
panesar k (2015) age-related macular degeneration. us pharmacist 40: 22-26. |
|
gaol ff. pria 50 tahun dengan ulserasi kornea dan hipopion. |
|
wozniak r, aquavella j (2015) considering keratitis: critical questions in disease management. rev optometry. |
|
schumann rg, haritoglou c, international chromovitrectomy collaboration (2013) chromovitrectomy and the vitreoretinal interface. ophthalmologica 230: 3-10. |
|
gelman r, stevenson w, prospero-ponce c, agarwal d, christoforidis jb (2015) retinal damage induced by internal limiting membrane removal. j ophthalmology. |
|
suzuki k, kiyoshi y, yasukawa t, aki k, kato a, et al. short term outcome of intravitreal injection of afli - bercepton against wet type age-related macular degeneration. clin ophthalmol 68: 1261-1267. |
|
kato a, yasukawa t, suga k, hirano y, nozaki m, et al. intravitreal ranibizumab for patients with neovascular age-related macular degeneration with good baseline visual acuity. ophthalmologica 233: 27-34. |
|
kato a, yasukawa t, ogura y (2014) antivascular endothelial growth factor therapies for neovascular age-related macular degeneration: search for the optimized treatment regimen. taiwan j ophthalmol 4: 3-8. |
|
yumusak e, kucukevcilioglu m, örnek k, buyuktortop n, örnek n (2016) effect of a single intravitreal ranibizumab injection on diabetic macular edema in patients who discontinued treatment. j clin exp invest. |
|
yasukawa t (2013) ‘proactive’versus ‘reactive’anti-vegf therapies for neovascular age-related macular degeneration: pros and cons. expert rev ophthalmol 8: 321-326. |
|
yasukawa t (2015) response-based individualized medicine for neovascular age-related macular degeneration. expert rev ophthalmol 10: 105-112. |
|
kato a, yasukawa t, ogura y (2014) antivascular endothelial growth factor therapies for neovascular age-related macular degeneration: search for the optimized treatment regimen. taiwan j ophthalmol 4: 3-8. |
|
hariprasad sm, morse ls, shapiro h, wong p, tuomi l (2012) fixed monthly versus less frequent ranibizumab dosing and predictors of visual response in exudative age-related macular degeneration. j ophthalmol. |
|
kim sy, moon by, cho hg (2013) investigation of instrument for photostress recovery time test in the eye. j korean ophthal optics soc 18: 193-196. |
|
stuart richer od (2015) bad blue light, macular pigment, and prescriptive carotenoids. optome times. |
|
emmick tk, alexander d. why dietary zeaxanthin?-a scientific summary. |
|
stuart richer od (2015) lutein and zeaxanthin: beyond retinal health. optome times. |
|
osman im, awad r, shi w, shousha ma (2016) suction loss during femtosecond laser–assisted small-incision lenticule extraction: incidence and analysis of risk factors. j cataract refract surgery 42: 246-250. |
|
syed za, melki sa (2014) successful femtosecond lasik flap creation despite multiple suction losses. digital j ophthalmol 20: 7. |
|
lešták j, tintera j, kyncl m, svatá z, rozsíval p (2013) high tension glaucoma and normal tension glaucoma in brain mri. j clin exp ophthalmol 4: 2. |
|